Comments to the Editor on “Outcomes and Costs of Risperidone versus Olanzapine in Patients with Chronic Schizophrenia or Schizoaffective Disorders- A Markov Model”

Mar 1, 2005, 00:00 AM
10.1111/j.1524-4733.2005.08204.x
https://www.valueinhealthjournal.com/article/S1098-3015(10)60260-4/fulltext
Section Title :
Section Order : 9
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)60260-4&doi=10.1111/j.1524-4733.2005.08204.x
HEOR Topics :
Tags :
Regions :